No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

byKathleen Lau

October 21, 2021

in StudyGraphics

Treatment of patent ductus arteriosus in very low birth weight infants varies between hospitals

RelatedReports

Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome

Chronic Disease

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

January 22, 2026

Patients with advanced adenomas are at increased risk of developing colorectal cancer

AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Prescription of antibiotics for acute respiratory infections increasing

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

#VisualAbstract: Fulvestrant-palbociclib and letrozole-palbociclib are equally effective for HR⁺ advanced breast cancer

#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer

Top 10 TV Shows to Binge Watch During Lockdown

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports